[1] SINGER M,DEUTSCHMAN CS,SEYMOUR CW,et al.The third international consensus definitions for sepsis and septic shock (sepsis-3)[J].JAMA,2016,315(8):801. doi: 10.1001/jama.2016.0287
[2] 王利华,黄利群,吕红博,等.参附注射液的药理作用与临床应用[J].华北国防医药,2010,22(6):535. doi: 10.3969/j.issn.2095-140X.2010.06.015
[3] 吴颖,崔朝勃,于立杰,等.乌司他丁的药理作用及临床应用[J].中国医药,2015,10(3):446. doi: 10.3760/cma.j.issn.1673-4777.2015.03.046
[4] RHODES A,EVANS LE,ALHAZZANI W,et al.Surviving Sepsis Campaign:International guidelines for management of sepsis and septic shock:2016[J].Crit Care Med,2017,45(3):486. doi: 10.1097/CCM.0000000000002255
[5] TAEB AM,HOOPER MH,MARIK PE.Sepsis:Current definition,pathophysiology,diagnosis,and management[J].Nutr Clin Pract,2017,32(3):296. doi: 10.1177/0884533617695243
[6] OPAL SM,VAN DPT.Endothelial barrier dysfunction in septic shock[J].J Intern Med,2015,277(3):277. doi: 10.1111/joim.12331
[7] 王磊,齐洪娜,张玮,等.参附注射液对严重脓毒症患者D-乳酸和炎性因子的影响[J].临床急诊杂志,2018,19(1):17.
[8] 沈琪琦,张之龄.参附注射液对脓毒症心肌损伤患者血浆BNP和炎性因子的影响[J].中国中医急症,2017,26(1):184. doi: 10.3969/j.issn.1004-745X.2017.01.060
[9] 张凯凯,于学忠,梁显泉,等.乌司他丁对脓毒症伴多器官衰竭患者血清降钙素原C反应蛋白及免疫功能的影响[J].中国急救医学,2018,38(4):328. doi: 10.3969/j.issn.1002-1949.2018.04.011
[10] 方旭晨,叶旭辉,涂春莲,等.连续血液净化联合乌司他丁治疗脓毒症休克疗效观察[J].内科急危重症杂志,2018,24(5):400.
[11] 田勇刚,乔鲁军,牟林,等.乌司他丁对重症脓毒症细胞因子表达水平的影响[J].中华医院感染学杂志,2015,25(23):5287.
[12] SAFARI S,SHOJAEE M,RAHMATI F,et al.Accuracy of SOFA score in prediction of 30-day outcome of critically ill patients[J].Turk J Emerg Med,2016,16(4):146. doi: 10.1016/j.tjem.2016.09.005
[13] 刘明双,彭芳,杨昆,等.脓毒症患者血清PCT水平与APACHEⅡ、SOFA评分相关性及预后评估[J].中外医学研究,2018,16(2):28.
[14] 周文杰,张小亚,张琚,等.APACHEⅡ和SOFA评分联合血清降钙素原对鲍曼不动杆菌血流感染患者预后的预测价值[J].中国急救医学,2017,37(3):221. doi: 10.3969/j.issn.1002-1949.2017.03.006
[15] SNIDER RH,NYLEN ES,BECKER KL.Procalcitonin and its component peptides in systemic inflammation:Immunochemical characterization[J].J Investig Med,1997,45(9):552.
[16] AZEVEDO JR,TORRES OJ,CZECZKO NG,et al.Procalcitonin as a prognostic biomarker of severe sepsis ang septic shock[J].Rev Col Bras Cir,2012,39(6):456. doi: 10.1590/S0100-69912012000600003
[17] 樊蕴挥,郝正玮,戈艳蕾,等.参附注射液治疗重度脓毒血症的效果及影响因素的Logistic回归分析[J].中医药导报,2016,22(14):64.
[18] ZHANG Z,XU X,CHEN K.Lactate clearance as a useful biomarker for the predicition of all-cause mortality in critically ill patients:A systematic review study protocol[J].BMJ Open,2014,4(5):e004752.